Back
BioLine Rx 10K Form
Sell
28
BLRX
BioLine Rx
Last Price:
0.65
Seasonality Move:
-5.08%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BLRX News And Ratings
See the #1 stock for the next 7 days that we like better than BLRX
BLRX Financial Statistics
Sales & Book Value
| Annual Sales: | $4.8M |
|---|---|
| Cash Flow: | $-11.36M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.17 |
| Price / Book: | 3.56 |
Profitability
| EPS (TTM): | -0.45350 |
|---|---|
| Net Income (TTM): | $-30.12M |
| Gross Margin: | $1.11M |
| Return on Equity: | -202.27% |
| Return on Assets: | -51.59% |
BioLine Rx Earnings Forecast
Key BioLine Rx Financial Ratios
- The Gross Profit Margin over the past 9 years for BLRX is 23.08%.
- The Selling, General & Administrative Expenses for BLRX have been equal to 650.63% of Gross Profit Margin.
- The Research & Development expenses have been 260.81% of Revenue.
- The Interest Expense is -3.54% of Operating Income.
- The Net Earning history of BLRX is -1,262.79% of Total Revenues.
- Per Share Earnings over the last 14 years have been positive in 9 years.
BioLine Rx Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | BLRX |
| CUSIP: | 09071M |
| Website: | biolinerx.com |
Debt
| Debt-to-Equity Ratio: | 2.11 |
|---|---|
| Current Ratio: | 1.61 |
| Quick Ratio: | 1.44 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
BLRX Technical Analysis vs Fundamental Analysis
Sell
28
BioLine Rx (BLRX)
is a Sell
Is BioLine Rx a Buy or a Sell?
-
BioLine Rx stock is rated a Sell
The current BioLine Rx [BLRX] share price is $0.62. The Score for BLRX is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.